StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · LNSR·Healthcare

LENSAR Inc Stock Analysis & AI Score

LENSAR Inc (LNSR) has an ST Score of 56.4 (B-), driven by its Forecast (A-) and held back by its Valuation (C-). Analysts rate it Buy with a $13.00 price target (+83.7% upside).

Market Closed
$7.08
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
56
ST Score
56.4/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Devices
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

LNSR
56.4out of 100
Grade B-

LENSAR Inc (LNSR) has an ST Score of 56.4 (B-), driven by its Forecast (A-) and held back by its Valuation (C-). Analysts rate it Buy with a $13.00 price target (+83.7% upside).

Strongest
ForecastA-
Weakest
ValuationC-
All factor grades
  • ForecastA-
  • ProfitabilityB
  • Financial StrengthB
  • MomentumC+
  • GrowthC+
  • ValuationC-
  • Piotroski5/9
Score methodology
Press Releases

Contact

LNSR stock: frequently asked questions

What is LNSR's ST Score?

LENSAR Inc (LNSR) has an ST Score of 56.4 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is LNSR a buy, hold, or sell?

Analysts rate LNSR a Buy, with a price target of $13.00 (+83.7% vs the current price). Our ST Score grades it B- (56.4/100). The ST Score is a data-driven signal, not a recommendation.

What are LNSR's factor grades?

Valuation C-, Profitability B, Financial Strength B, Momentum C+, Growth C+, Forecast A-.

What is LNSR's valuation grade?

LENSAR Inc (LNSR) earns a valuation grade of C-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is LNSR's growth grade?

LENSAR Inc (LNSR) earns a growth grade of C+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is LNSR's profitability grade?

LENSAR Inc (LNSR) earns a profitability grade of B, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is LNSR's financial strength grade?

LENSAR Inc (LNSR) earns a financial strength grade of B, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for LNSR?

The average analyst price target for LENSAR Inc (LNSR) is $13.00 from 3 analysts, which is +83.7% versus the recent price of $7.08.

What is LNSR's Piotroski score?

LENSAR Inc (LNSR) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.